Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0049ATC

KHYG-1 Human Peripheral Blood Immune Cells

Tumor Cell Lines > Leukemia Cell Lines

Product Type: Human Leukemia Cell Lines

Species: Human

Cell Type: Immune Cells

Source Organ: Blood

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: KHYG-1

KHYG-1 was established 1997 from the peripheral blood of a 45-year-old woman with aggressive natural killer cell (NK) leukemia. Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells.

  • Description
    KHYG-1 is a human natural killer (NK) leukemia cell line derived from the peripheral blood of a 45-year-old woman with aggressive NK cell leukemia. This cell line exhibits the morphology of large granular lymphocytes, characterized by a large nucleus, coarse chromatin, prominent nucleoli, and abundant basophilic cytoplasm containing many azurophilic granules. Immunophenotype of KHYG-1 includes markers such as CD2+, CD7+, CD56+, and CD122+, while it is negative for CD1, CD3, CD16, and CD57. KHYG-1 harbors a point mutation in exon 7 of the p53 gene, a mutation also found in primary leukemia cells, making it an ideal model for studying p53-associated leukemogenesis. KHYG-1 cells demonstrate high cytotoxicity against various leukemia cell lines, including EM2, EM3, and HL60, and this cytolytic activity is thought to be mediated by activation receptors such as NKp44, NKG2D, and phosphorylated ERK2. They are valuable for research into NK/T cell differentiation and leukemia therapy.
  • Product Name
    KHYG-1
  • Product Type
    Human Leukemia Cell Lines
  • Species
    Human
  • Cell Type
    Lymphocyte-like
  • Source Organ
    Peripheral Blood
  • Product Type
    Human Leukemia Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    KHYG-1 provides a valuable model for studying the biology of normal and malignant NK cells, and leukemogenesis. NK cells have been considered promising candidates for adoptive immunotherapy of malignancies, however, the endogenous NK and lymphokine-activated killer cells show limited cytotoxic activity. Through the investigation of enhanced cytotoxicity of permanent NK cell lines, such as KHYG-1, the limitation of autologous NK cells may be overcome, and NK cells may achieve enhanced cytotoxic potential clinically.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS + 100 units/mL recombinant human IL-2
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you